REG - PureTech Health PLC - Transaction in Own Shares

Puretech HealthAnnouncement

08/02/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240208:nRSH3980Ca&default-theme=true

RNS Number : 3980C  PureTech Health PLC  08 February 2024

8 February 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"). This completes the Share Buyback
Programme of up to $50 million, details of which were announced on 9 May 2022.
Between 9 May 2022 and 7 February 2024, the Company repurchased an aggregate
of 20,182,863 ordinary shares under the Share Buyback Programme, which
represents approximately 7% of the Company's issued share capital at the time
the programme commenced. The Company intends to update its capital return
strategy in light of the expected closing of the pending merger between its
Founded Entity, Karuna Therapeutics, Inc. (Nasdaq: KRTX), and Bristol Meyers
Squibb (NYSE: BMY).

 

 Date of purchase:                              7 February 2024

 Number of ordinary shares purchased:           23,059

 Highest price paid per share:                  195.20p

 Lowest price paid per share:                   188.00p

 Volume weighted average price paid per share:  190.25p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 19,518,418 ordinary
shares in treasury and has 269,949,741 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 269,949,741 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 28 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/)  or connect with us on X, formerly known as
Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

 Transaction Date  Transaction Time  Volume  Price (GBp)  Platform  Transaction Reference Number
 07/02/2024        09:09:29          571     195.2        XLON      00389031421TRLO0.1.1
 07/02/2024        09:09:29          117     195          CHIX      00389031422TRLO0.1.1
 07/02/2024        09:09:29          117     195          CHIX      00389031423TRLO0.1.1
 07/02/2024        09:09:29          45      195          AQXE      00389031424TRLO0.1.1
 07/02/2024        09:09:29          62      194.8        BATE      00389031425TRLO0.1.1
 07/02/2024        09:09:29          27      194.8        BATE      00389031426TRLO0.1.1
 07/02/2024        09:10:17          571     194.4        XLON      00389031580TRLO0.1.1
 07/02/2024        09:10:17          21      194.4        TRQX      00389031581TRLO0.1.1
 07/02/2024        09:15:54          26      192.6        BATE      00389032428TRLO0.1.1
 07/02/2024        09:15:54          63      192.6        BATE      00389032429TRLO0.1.1
 07/02/2024        09:15:54          1142    193          XLON      00389032430TRLO0.1.1
 07/02/2024        09:15:54          45      192.2        AQXE      00389032433TRLO0.1.1
 07/02/2024        09:15:54          21      192          TRQX      00389032434TRLO0.1.1
 07/02/2024        10:14:41          267     192.8        XLON      00389043185TRLO0.1.1
 07/02/2024        10:14:41          16      193          XLON      00389043186TRLO0.1.1
 07/02/2024        10:14:41          288     193          XLON      00389043187TRLO0.1.1
 07/02/2024        11:00:21          534     192.4        XLON      00389051703TRLO0.1.1
 07/02/2024        11:41:58          608     193          XLON      00389057869TRLO0.1.1
 07/02/2024        11:44:36          240     193          XLON      00389058239TRLO0.1.1
 07/02/2024        12:48:39          8       193          AQXE      00389067816TRLO0.1.1
 07/02/2024        12:51:45          103     193          CHIX      00389068583TRLO0.1.1
 07/02/2024        12:51:45          32      193          AQXE      00389068582TRLO0.1.1
 07/02/2024        12:51:45          78      193          XLON      00389068584TRLO0.1.1
 07/02/2024        12:51:45          571     193          XLON      00389068586TRLO0.1.1
 07/02/2024        12:51:45          493     193          XLON      00389068585TRLO0.1.1
 07/02/2024        13:25:09          40      192.4        AQXE      00389075458TRLO0.1.1
 07/02/2024        13:25:09          78      192.2        BATE      00389075459TRLO0.1.1
 07/02/2024        13:25:09          78      192.2        BATE      00389075460TRLO0.1.1
 07/02/2024        13:25:09          103     192.2        CHIX      00389075461TRLO0.1.1
 07/02/2024        13:25:09          571     192.4        XLON      00389075462TRLO0.1.1
 07/02/2024        13:25:09          234     192.4        XLON      00389075463TRLO0.1.1
 07/02/2024        13:25:09          18      191.8        TRQX      00389075464TRLO0.1.1
 07/02/2024        13:26:52          651     191.4        XLON      00389075653TRLO0.1.1
 07/02/2024        13:31:08          18      191.8        TRQX      00389076419TRLO0.1.1
 07/02/2024        14:09:45          18      191.8        TRQX      00389082617TRLO0.1.1
 07/02/2024        14:13:20          103     191.6        CHIX      00389083083TRLO0.1.1
 07/02/2024        14:13:36          2       191.6        BATE      00389083110TRLO0.1.1
 07/02/2024        14:36:31          103     190.8        CHIX      00389091584TRLO0.1.1
 07/02/2024        14:36:31          18      191          TRQX      00389091585TRLO0.1.1
 07/02/2024        14:36:31          18      191          TRQX      00389091586TRLO0.1.1
 07/02/2024        14:36:31          502     191          XLON      00389091587TRLO0.1.1
 07/02/2024        14:36:31          326     191          XLON      00389091588TRLO0.1.1
 07/02/2024        14:36:31          164     191          XLON      00389091589TRLO0.1.1
 07/02/2024        14:36:31          40      190.6        AQXE      00389091592TRLO0.1.1
 07/02/2024        14:36:31          76      191          BATE      00389091594TRLO0.1.1
 07/02/2024        14:36:35          40      189.8        AQXE      00389091636TRLO0.1.1
 07/02/2024        14:36:35          40      189.8        AQXE      00389091635TRLO0.1.1
 07/02/2024        14:36:35          3       189.8        BATE      00389091637TRLO0.1.1
 07/02/2024        14:36:35          67      189.8        BATE      00389091639TRLO0.1.1
 07/02/2024        14:36:35          78      189.8        BATE      00389091638TRLO0.1.1
 07/02/2024        14:37:24          571     190.2        XLON      00389092059TRLO0.1.1
 07/02/2024        14:55:58          103     190.8        CHIX      00389103460TRLO0.1.1
 07/02/2024        15:00:32          40      190          AQXE      00389106075TRLO0.1.1
 07/02/2024        15:00:32          601     190          XLON      00389106076TRLO0.1.1
 07/02/2024        15:00:32          377     190          XLON      00389106077TRLO0.1.1
 07/02/2024        15:00:32          9       189.8        CHIX      00389106078TRLO0.1.1
 07/02/2024        15:00:35          91      189.8        CHIX      00389106121TRLO0.1.1
 07/02/2024        15:01:02          3       189.8        CHIX      00389106355TRLO0.1.1
 07/02/2024        15:02:13          430     189.8        XLON      00389106922TRLO0.1.1
 07/02/2024        15:02:13          141     189.8        XLON      00389106923TRLO0.1.1
 07/02/2024        15:02:23          78      189.2        BATE      00389106980TRLO0.1.1
 07/02/2024        15:02:23          278     189.2        XLON      00389106982TRLO0.1.1
 07/02/2024        15:02:23          864     189.2        XLON      00389106981TRLO0.1.1
 07/02/2024        15:10:33          18      189          TRQX      00389112269TRLO0.1.1
 07/02/2024        16:04:31          91      188.8        XLON      00389146229TRLO0.1.1
 07/02/2024        16:04:31          480     188.8        XLON      00389146230TRLO0.1.1
 07/02/2024        16:21:50          3162    188.2        XLON      00389157053TRLO0.1.1
 07/02/2024        16:21:50          1200    188.2        XLON      00389157054TRLO0.1.1
 07/02/2024        16:23:01          18      188          XLON      00389157762TRLO0.1.1
 07/02/2024        16:23:01          1000    188          XLON      00389157763TRLO0.1.1
 07/02/2024        16:23:04          228     188          XLON      00389157785TRLO0.1.1
 07/02/2024        16:23:04          600     188          XLON      00389157784TRLO0.1.1
 07/02/2024        16:23:10          934     188          XLON      00389157848TRLO0.1.1
 07/02/2024        16:23:10          227     188          XLON      00389157849TRLO0.1.1
 07/02/2024        16:23:10          934     188          XLON      00389157850TRLO0.1.1
 07/02/2024        16:23:32          207     188          XLON      00389158078TRLO0.1.1
 07/02/2024        16:23:43          441     188          XLON      00389158159TRLO0.1.1
 07/02/2024        16:24:24          64      188          XLON      00389158455TRLO0.1.1
 07/02/2024        16:25:49          12      188          XLON      00389159344TRLO0.1.1
 07/02/2024        16:29:22          402     188          XLON      00389161966TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSFLFVDFTIDIIS